RECURRENT NON-SMALL CELL LUNG CARCINOMA
Clinical trials for RECURRENT NON-SMALL CELL LUNG CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT NON-SMALL CELL LUNG CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT NON-SMALL CELL LUNG CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo tested to fight tough cancers
Disease control CompletedThis study tested whether combining an experimental drug (sEphB4-HSA) with an approved immunotherapy (pembrolizumab) could help control advanced lung and head/neck cancers. It involved 42 patients whose cancer had progressed after standard chemotherapy. The goal was to see if the…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: University of Southern California • Aim: Disease control
Last updated Apr 04, 2026 06:38 UTC
-
New drug combo tested as last hope for tough lung cancers
Disease control CompletedThis study tested a combination of two oral drugs, auranofin and sirolimus, for patients with advanced or returning lung cancer who had run out of standard treatment options. The main goals were to find the safest dose and see if the treatment could slow the cancer's growth. The …
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Vaccine-Immunotherapy combo tested in Tough-to-Treat lung cancer
Disease control CompletedThis study tested whether combining a cancer vaccine (TG4010) with an immunotherapy drug (nivolumab) could help control advanced non-small cell lung cancer in patients whose previous treatments had stopped working. The vaccine aims to train the immune system to recognize and atta…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: Megan Daly, MD • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Diabetes drug added to lung cancer treatment in groundbreaking trial
Disease control CompletedThis study tested whether adding the common diabetes medication metformin to standard chemotherapy and radiation could better control stage III non-small cell lung cancer. Researchers randomly assigned 170 patients with inoperable lung cancer to receive either the standard treatm…
Matched conditions: RECURRENT NON-SMALL CELL LUNG CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC